Prinston Pharmaceutical Inc. has recalled approximately 21,987 bottles of Valsartan (160 mg), a prescription blood pressure medication. This recall was initiated after a customer reported finding tablets that were thicker and heavier than they should be within the bottle. Consumers should be aware that these tablets may contain an incorrect dosage or fail to meet quality standards. If you have this medication, you should contact your doctor or pharmacist to discuss an alternative treatment before you stop taking your prescribed dose.
The presence of thicker and heavier tablets indicates a manufacturing failure that can result in patients receiving an inconsistent or incorrect dose of their blood pressure medication. Taking an incorrect dosage could lead to ineffective management of blood pressure or potential adverse health effects from receiving more medication than intended.
Contact healthcare provider and return product to pharmacy.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.